Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Nov 19;123(3):651–660. doi: 10.1007/s10549-009-0632-6

Fig. 2.

Fig. 2

Recurrence-free survival and overall survival in untreated and Tam treated patients according to nuclear (a) and cytoplasmic (b) IRS-1 levels. *P-value based upon Wilcoxon test